Anavex Life Sciences Corp (AVXL)

[boi568]

Moving to Q and A --

What are EMA expectations? Conditional or full approval? " We don't know." No updates but "very excited." (Of course)

Head count plans? Have been very conservative. Will depend on marketing approach.

When to expect new trial announcement? Focusing on MAA review. Probably PD trial up next. No timing provided. "Excited about it."

How confident in EMA approval? Can't tell, because not in charge of the decision. "Excited."

Manufacturing of 2-73? Fulfilled EMA required batches for marketing.

Sex dependent effect in 2b/3? No difference.

Have a plan to show 2b/3 OLE against ADNI? Eventually

Is new FDA positive or negative for Anavex? Can't tell

Post HP Morgan? Pick up of interest, meetings have proceeded

Plans to create more analyst coverage? High confidence it will pick up.

Marketing? Eventually Anavex wants to do the marketing

Why no accelerated approval in EMA? Not our purview

Expect to be bought out? Whatever's best for shareholders

Any thoughts in new European S1 org? We will attend, we are very plugged in

Gene data in OLE? Might look into that

Update on EMA approval process? Just repeats standard time line

These were Mayo's questions, I believe.

Call over.

No mention or any indication of a withdrawal.

PS -- I had a few questions, but it seemed like they weren't seen.